United Therapeutics Corporation (Nasdaq: UTHR) announced today that FDA has approved TYVASO (treprostinil) Inhalation Solution for ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE